Autolus Therapeutics AUTL
NASDAQ AUTL
$1.78 -0.07 (-3.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Autolus Therapeutics (AUTL) Non Operating Investment Income (2022 - 2025)

Updated

Autolus Therapeutics (AUTL) posted Non Operating Investment Income of -$3,000 for Q1 2025.

Analysis

Autolus Therapeutics (AUTL) Non Operating Investment Income (2022 - 2025) Analysis & Trends

For FY2024, Autolus Therapeutics' Non Operating Investment Income came in at -$223,000.

  • In prior years, Autolus Therapeutics' Non Operating Investment Income was -$3.79 million in FY2023, -$515,000 in FY2022 and -$676,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Autolus Therapeutics 631.98 Mn -692.11 Mn 25.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -3,000.00
Sep 30, 2024 -223,000.00
Jun 30, 2023 -23,000.00
Mar 31, 2023 -3.77 Mn
Dec 31, 2022 -515,000.00
API Access

Autolus Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=AUTL&period=max&api_key=YOUR_API_KEY